Author

B Kelch

Observed name: Benjamin P. Kelch

Observed institution: Hahnemann University Hospital

OpenAlex ID: A5113767797

RBC improved survival due to recombinant human erythropoietin explains effectiveness of less frequent, low dose subcutaneous therapy.

1992 · A B Schwartz, S B Kahn, et al. · PubMed · 18

One year of rHuEPO therapy prolongs RBC survival and may stabilize RBC membranes despite natural progression of chronic renal failure to uremia and need for dialysis.

1990 · A B Schwartz, B Kelch, et al. · PubMed · 18

An Unusual Extramedullary Relapse of Acute Nonlymphocytic Leukemia After Allogeneic Bone Marrow Transplantation

1990 · Benjamin P. Kelch, Stephen I. Bulova, et al. · American Journal of Clinical Oncology · 4

Works count: 3

Citation count: 40

H-index: 3

I10-index: 2